Next-generation sequencing methodologies to identify patients for targeted therapy: focus on HR+/HER2- metastatic breast cancer.

Saved in:
Bibliographic Details
Title: Next-generation sequencing methodologies to identify patients for targeted therapy: focus on HR+/HER2- metastatic breast cancer.
Authors: Malapelle U; Department of Public Health, University Federico II of Naples, Naples, Italy., Buglioni S; Department of Pathology, IRCCS National Cancer Institute Regina Elena, Rome, Italy., Castellano I; Department of Medical Sciences, University of Turin, Turin, Italy., Criscitiello C; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Division of Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy., Curigliano G; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Division of Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy., d'Amati G; Department of Radiological, Oncological and Pathological Sciences, Sapienza-University of Rome, Rome, Italy., De Angelis C; Clinical and Translational Oncology, Scuola Superiore Meridionale, Naples, Italy., de Biase D; Department of Pharmacy and Biotechnology (FABIT), University of Bologna, Bologna, Italy.; Solid Tumor Molecular Pathology Laboratory, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Pepe F; Department of Public Health, University Federico II of Naples, Naples, Italy., Perrone G; Operative Research Unit of Anatomical Pathology, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy.; Department of Medicine, Research Unit of Anatomical Pathology, Università Campus Bio-Medico di Roma, Rome, Italy., Scatena C; Division of Pathology, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.; Department of Oncology, Pisa University Hospital, Pisa, Italy., Scatolini M; Molecular Oncology Laboratory, Fondazione Edo ed Elvo Tempia, Ponderano, Biella, Italy., Trapani D; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Division of Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy., Venetis K; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy., Fusco N; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy.
Source: Pathologica [Pathologica] 2025 Dec; Vol. 117 (6), pp. 546-558.
Publication Type: Journal Article; Review
Journal Info: Publisher: Pacini Editore SpA Country of Publication: Italy NLM ID: 0401123 Publication Model: Print Cited Medium: Internet ISSN: 1591-951X (Electronic) Linking ISSN: 00312983 NLM ISO Abbreviation: Pathologica Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1591-951X
DOI:10.32074/1591-951X-1531